Currently out of the existing stock ratings of Maury Raycroft, 90 are a BUY (79.65%), 23 are a HOLD (20.35%).

Maury Raycroft

Work Performance Price Targets & Ratings Chart

Analyst Maury Raycroft, currently employed at JEFFERIES, carries an average stock price target met ratio of 51.78% that have a potential upside of 35.26% achieved within 149 days.

Maury Raycroft’s has documented 245 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SGMO, Sangamo Therapeutics at 31-Dec-2024.

Wall Street Analyst Maury Raycroft

Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for ALNY (ALNYLAM PHARMACEUTICALS) at 9/18/2017. The price target of $102 was fulfilled within 2 days with a profit of $26 (34.21%) receiving and performance score of 171.05.

Average potential price target upside

of $125.5 (28.03%) on ATRA (ATARA BIOTHERAPEUTICS).
of $47.4 (97.11%) on ALLK (ALLAKOS).
of $30.92 (23.08%) on ALNY (ALNYLAM PHARMACEUTICALS).

AFMD Affimed NV ARWR Arrowhead Pharmaceuticals ATRA Atara Biotherapeutics AYLA Ayala Pharmaceuticals BCRX BioCryst Pharmaceuticals CRBP Corbus Pharmaceuticals CRSP Crispr Therapeutics AG KALV Kalvista Pharmaceuticals MRTX Mirati Ther RETA Reata Pharmaceuticals SRRA Sierra Oncology ALLK Allakos ABEO Abeona Therapeutics ALNY Alnylam Pharmaceuticals EIGR Eiger Biopharmaceuticals NTLA Intellia Therapeutics BYSI BeyondSpring VALN Valneva SE ADR XENE Xenon Pharmaceuticals FMTX Forma Therapeutics Holdings KPTI Karyopharm Therapeutics RARE Ultragenyx SGMO Sangamo Therapeutics IMGO Imago Biosciences VERA Vera Therapeutics CNST Constellation Pharmaceuticals RTRX Travere Therapeutics SBPH Spring Bank Pharmaceuticals THRX Theseus Pharmaceuticals TYRA Tyra Biosciences RZLT Rezolute SPPI Spectrum Pharmaceuticals KZR Kezar Life Sciences AUPH Aurinia Pharmaceuticals CALT Calliditas Therapeutics CMPX Compass Therapeutics CUE Cue Biopharma

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Swayampakula Ramakanth (HC WAINWRIGHT)